116 related articles for article (PubMed ID: 1987874)
1. Lymphoproliferative responses to Borrelia burgdorferi in Lyme disease.
Zoschke DC; Skemp AA; Defosse DL
Ann Intern Med; 1991 Feb; 114(4):285-9. PubMed ID: 1987874
[TBL] [Abstract][Full Text] [Related]
2. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
[TBL] [Abstract][Full Text] [Related]
3. The T-cell proliferative assay in the diagnosis of Lyme disease.
Dressler F; Yoshinari NH; Steere AC
Ann Intern Med; 1991 Oct; 115(7):533-9. PubMed ID: 1883122
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte proliferation assay in response to Borrelia burgdorferi in patients with Lyme arthritis: analysis of lymphocyte subsets.
Rutkowski S; Busch DH; Huppertz HI
Rheumatol Int; 1997; 17(4):151-8. PubMed ID: 9440146
[TBL] [Abstract][Full Text] [Related]
5. Antigens of Lyme disease of spirochaete Borrelia burgdorferi inhibits antigen or mitogen-induced lymphocyte proliferation.
Chiao JW; Pavia C; Riley M; Altmann-Lasekan W; Abolhassani M; Liegner K; Mittelman A
FEMS Immunol Med Microbiol; 1994 Feb; 8(2):151-5. PubMed ID: 8173554
[TBL] [Abstract][Full Text] [Related]
6. Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi.
Dattwyler RJ; Volkman DJ; Luft BJ; Halperin JJ; Thomas J; Golightly MG
N Engl J Med; 1988 Dec; 319(22):1441-6. PubMed ID: 3054554
[TBL] [Abstract][Full Text] [Related]
7. T cell proliferation induced by Borrelia burgdorferi in patients with Lyme borreliosis. Autologous serum required for optimum stimulation.
Krause A; Brade V; Schoerner C; Solbach W; Kalden JR; Burmester GR
Arthritis Rheum; 1991 Apr; 34(4):393-402. PubMed ID: 2012626
[TBL] [Abstract][Full Text] [Related]
8. Lymphoproliferative responses to Borrelia burgdorferi in the diagnosis of Lyme arthritis in children and adolescents.
Huppertz HI; Mösbauer S; Busch DH; Karch H
Eur J Pediatr; 1996 Apr; 155(4):297-302. PubMed ID: 8777923
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW
Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448
[TBL] [Abstract][Full Text] [Related]
10. Borrelia burgdorferi-specific immune complexes in acute Lyme disease.
Schutzer SE; Coyle PK; Reid P; Holland B
JAMA; 1999 Nov; 282(20):1942-6. PubMed ID: 10580460
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of Th17 cytokines in the culture of peripheral blood mononuclear cells stimulated with Borrelia burgdorferi sensu lato.
Grygorczuk S; Świerzbińska R; Moniuszko A; Kondrusik M; Zajkowska J; Czupryna P; Dunaj J; Pancewicz S
Ann Agric Environ Med; 2016 Jun; 23(2):242-7. PubMed ID: 27294626
[TBL] [Abstract][Full Text] [Related]
12. Sarcoidosis and ELISA for Borrelia burgdorferi.
Morris JT; Longfield RN
South Med J; 1994 Jun; 87(6):590-1. PubMed ID: 8202765
[TBL] [Abstract][Full Text] [Related]
13. An Enzyme-Linked Immunosorbent Spot Assay Measuring Borrelia burgdorferi B31-Specific Interferon Gamma-Secreting T Cells Cannot Discriminate Active Lyme Neuroborreliosis from Past Lyme Borreliosis: a Prospective Study in the Netherlands.
van Gorkom T; Sankatsing SUC; Voet W; Ismail DM; Muilwijk RH; Salomons M; Vlaminckx BJM; Bossink AWJ; Notermans DW; Bouwman JJM; Kremer K; Thijsen SFT
J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29367297
[TBL] [Abstract][Full Text] [Related]
14. Lymphoproliferative responses to Borrelia burgdorferi in circumscribed scleroderma.
Breier P; Klade H; Stanek G; Poitschek C; Kirnbauer R; Dorda W; Aberer E
Br J Dermatol; 1996 Feb; 134(2):285-91. PubMed ID: 8746343
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of a B-lymphocyte mitogen produced by the Lyme disease pathogen, Borrelia burgdorferi.
Schoenfeld R; Araneo B; Ma Y; Yang LM; Weis JJ
Infect Immun; 1992 Feb; 60(2):455-64. PubMed ID: 1730476
[TBL] [Abstract][Full Text] [Related]
16. [Lymphocyte proliferation test in cutaneous manifestations of Lyme borreliosis].
Breier F; Klade H; Stanek G
Wien Med Wochenschr; 1995; 145(7-8):170-3. PubMed ID: 7610666
[TBL] [Abstract][Full Text] [Related]
17. Long-term persistence of specific T- and B-lymphocyte responses to Borrelia burgdorferi following untreated neuroborreliosis.
Krüger H; Pulz M; Martin R; Sticht-Groh V
Infection; 1990; 18(5):263-7. PubMed ID: 2276818
[TBL] [Abstract][Full Text] [Related]
18. Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection.
Pohl-Koppe A; Balashov KE; Steere AC; Logigian EL; Hafler DA
J Immunol; 1998 Feb; 160(4):1804-10. PubMed ID: 9469440
[TBL] [Abstract][Full Text] [Related]
19. Sustained cellular immune responses to Borrelia burgdorferi: lack of correlation with clinical presentation and serology.
Horowitz HW; Pavia CS; Bittker S; Forseter G; Cooper D; Nadelman RB; Byrne D; Johnson RC; Wormser GP
Clin Diagn Lab Immunol; 1994 Jul; 1(4):373-8. PubMed ID: 8556471
[TBL] [Abstract][Full Text] [Related]
20. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease.
Kalish RA; McHugh G; Granquist J; Shea B; Ruthazer R; Steere AC
Clin Infect Dis; 2001 Sep; 33(6):780-5. PubMed ID: 11512082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
